Neoleukin Therapeutics (NLTX) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NLTX Stock Alerts $37.16 -0.31 (-0.83%) (As of 06/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 14, 2024 | marketbeat.comNeoleukin Therapeutics (NASDAQ:NLTX) Shares Down 0.8% Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 0.8%December 20, 2023 | finance.yahoo.comIs Neoleukin Therapeutics (NASDAQ:NLTX) In A Good Position To Invest In Growth?December 15, 2023 | finance.yahoo.comNeoleukin Therapeutics Announces 1-for-4 Reverse Stock SplitDecember 4, 2023 | benzinga.comNeoleukin Therapeutics Stock (NASDAQ:NLTX) Dividends: History, Yield and DatesOctober 5, 2023 | markets.businessinsider.comPre-market Movers: ORTX, CMBM, GROM, RSVR, FEMY…September 26, 2023 | finanznachrichten.deNeoleukin Therapeutics, Inc.: Neoleukin Therapeutics Announces 1-for-5 Reverse Stock SplitSeptember 22, 2023 | finance.yahoo.comNeoleukin Therapeutics Announces 1-for-5 Reverse Stock SplitAugust 18, 2023 | benzinga.comNeoleukin Therapeutics Recent Insider ActivityAugust 18, 2023 | finance.yahoo.comBAKER BROS. ADVISORS LP Reduces Stake in Neoleukin Therapeutics IncAugust 8, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCUAugust 1, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTXJuly 28, 2023 | finance.yahoo.comRedmile Group, LLC Boosts Stake in Neoleukin Therapeutics IncJuly 26, 2023 | benzinga.comMoore Kuehn Encourages AMNB, SCU, NLTX, and PRDS Investors to Contact Law FirmJuly 24, 2023 | 247wallst.comBaker Bros. Advisors Now Owns 19.99% of Neoleukin TherapeuticsJuly 19, 2023 | markets.businessinsider.comNeurogene, Neoleukin Announce Planned MergerJuly 18, 2023 | msn.comUniv. of Washington spinout Neoleukin Therapeutics merging with New York City startupJuly 18, 2023 | finanznachrichten.deNeoleukin Therapeutics, Inc.: Neurogene and Neoleukin Announce Definitive Merger AgreementJuly 18, 2023 | benzinga.comNeoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological DiseasesJuly 18, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQJuly 18, 2023 | msn.comNeoleukin jumps 7% on Neurogene mergerJuly 18, 2023 | marketwatch.comNeoleukin Therapeutics Shares Rise Premarket on Reverse Merger Deal >NLTXJuly 18, 2023 | technews.tmcnet.comNLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to ShareholdersJuly 18, 2023 | finance.yahoo.comNeurogene and Neoleukin Announce Definitive Merger AgreementMay 23, 2023 | finance.yahoo.comBiomed Industries, Inc. Offers to acquire Neoleukin Therapeutics, Inc. (NASDAQ:NLTX)May 9, 2023 | markets.businessinsider.comMizuho Securities Reaffirms Their Hold Rating on Neoleukin Therapeutics (NLTX)April 7, 2023 | bizjournals.comNeoleukin Therapeutics promotes general counsel to interim CEOMarch 31, 2023 | seekingalpha.comNLTX Neoleukin Therapeutics, Inc.March 21, 2023 | markets.businessinsider.comNeoleukin Therapeutics (NLTX) Receives a Hold from Mizuho SecuritiesMarch 10, 2023 | finance.yahoo.comHere's Why We're Watching Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn SituationMarch 10, 2023 | bizjournals.comSeattle biotech company CEO steps down amid steep job cutsMarch 9, 2023 | marketwatch.comNeoleukin Therapeutics Shares Climb 29% on 70% Workforce Reduction, Strategic AlternativesMarch 9, 2023 | msn.comShares of Neoleukin Therapeutics spike after announcing layoffs and potential sale or mergerMarch 9, 2023 | finance.yahoo.comNeoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 MonthsMarch 9, 2023 | msn.comNeoleukin Therapeutics to cut 70% workforce, CEO steps downMarch 8, 2023 | marketwatch.comNeoleukin Therapeutics Eyes Strategic Alternatives, Will Cut StaffMarch 8, 2023 | markets.businessinsider.comMizuho Securities Keeps Their Hold Rating on Neoleukin Therapeutics (NLTX)March 8, 2023 | finance.yahoo.comNeoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership TransitionDecember 12, 2022 | finance.yahoo.comNeoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual MeetingNovember 16, 2022 | finance.yahoo.comNeoleukin (NLTX) Stops Development of Lead Drug, Stock DownNovember 15, 2022 | markets.businessinsider.comMizuho Securities downgrades Neoleukin Therapeutics (NLTX) to a HoldNovember 15, 2022 | finance.yahoo.comNeoleukin Pauses Development Of NL-201, Cuts 40% Of Employee StrengthNovember 15, 2022 | seekingalpha.comNeoleukin cut to Hold at Stifel on plans to drop lead assetNovember 15, 2022 | markets.businessinsider.com5 Analysts Have This to Say About Neoleukin TherapeuticsNovember 15, 2022 | finance.yahoo.comNeoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate UpdateNovember 14, 2022 | marketbeat.comTrading was temporarily halted for "NLTX" at 04:11 PM with a stated reason of "News pending."November 3, 2022 | finance.yahoo.comNeoleukin Therapeutics Announces Oral Presentation at 64th American Society of Hematology (ASH) Annual MeetingOctober 1, 2022 | finance.yahoo.comWe're Keeping An Eye On Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn RateAugust 10, 2022 | seekingalpha.comNeoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2022 Results - Earnings Call TranscriptAugust 10, 2022 | seekingalpha.comNeoleukin Therapeutics, Inc. 2022 Q2 - Results - Earnings Call PresentationAugust 9, 2022 | msn.comRecap: Neoleukin Therapeutics Q2 Earnings Get Neoleukin Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Don't Worry… (Ad)If you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge... And send three overlooked stocks soaring 1,000%+ Get my new research on all three plays right now. NLTX Media Mentions By Week NLTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NLTX News Sentiment▼0.000.73▲Average Medical News Sentiment NLTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NLTX Articles This Week▼00▲NLTX Articles Average Week Get Neoleukin Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Organogenesis News XBiotech News SIGA Technologies News Relmada Therapeutics News Spyre Therapeutics News Kiniksa Pharmaceuticals News ANI Pharmaceuticals News Akero Therapeutics News MannKind News Mirum Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NLTX) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredWhat Nvidia insiders don’t want you to knowIf you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge...Behind the Markets | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored